CellPlan selects Surely to power its Quote & Buy platform

CellPlan has selected Surely’s Quote and Buy platform to underpin its international rollout. CellPlan is part of the WideCells Group, the Worldwide Provider of Stem Cell Services that listed on the LSE last year (EPIC:WDC). The group is leading a transformation in cord blood banking and stem cell treatment, making cord blood banking more accessible through insurance coverage, and increasing the availability of cord blood for transplants. CellPlan, one of its 3 divisions, provides the first global stem cell treatment insurance plan, unlocking the potential of cord blood banking.

After conducting a review of the market, CellPlan selected Surely to provide its Quote and Buy system, allowing customers to obtain a quote online, purchase CellPlan, and obtain all the relevant documentation. Back-end checks with the core blood bank partners will also be handled by the platform. The solution will be launched initially in the UK, and will then be rolled out to international countries over the next 18 months, with additional product lines anticipated too.

Joao Andrade, CEO of WideCells Group, said: “Having successfully established the world’s first stem cell insurance plan, CellPlan, we are now focussed on promoting global uptake of this potentially life-saving product. To support this, we wanted a modern platform built on the latest technology, that can support customers purchasing our policies in the easiest possible way, with a strong focus on a clean and attractive user journey, support for all devices, and the ability to scale rapidly to multiple countries, currencies and languages. We are delighted to be working with Surely to achieve this and have been impressed with Surely’s mission to power digital insurance via their technology, their responsiveness and agility. In line with our fast paced development approach, we expect to launch our UK site within just 6 weeks of signing our contract with Surely and look forward to the significant opportunities ahead.”

Larry Shapiro, CEO of Surely, said: “We are delighted to have CellPlan as our newest customer, benefitting from the substantial investment we have made over the past 3 years into designing and building a flexible Quote and Buy cloud-based platform for the insurance industry. We are inspired by CellPlan’s ambitious vision for insurance to support stem cell treatments, and by their wider vision for the WideCells Group”.

Cellplan logo